Department of Medicine III, Technical University Dresden, 01307 Dresden, Germany.
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14801-6. doi: 10.1073/pnas.1313945110. Epub 2013 Aug 19.
Inflammation-related dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is central to the course of systemic inflammatory response syndrome or sepsis. The underlying mechanisms, however, are not well understood. Initial activation of adrenocortical hormone production during early sepsis depends on the stimulation of hypothalamus and pituitary mediated by cytokines; in late sepsis, there is a shift from neuroendocrine to local immune-adrenal regulation of glucocorticoid production. Therefore, the modulation of the local immune-adrenal cross talk, and not of the neuroendocrine circuits involved in adrenocorticotropic hormone production, may be more promising in the prevention of the adrenal insufficiency associated with prolonged sepsis. In the present work, we investigated the function of the crucial Toll-like receptor (TLR) adaptor protein myeloid differentiation factor 88 (MyD88) in systemic and local activation of adrenal gland inflammation and glucocorticoid production mediated by lipopolysachharides (LPSs). To this end, we used mice with a conditional MyD88 allele. These mice either were interbred with Mx1 Cre mice, resulting in systemic MyD88 deletion, predominantly in the liver and hematopoietic system, or were crossed with Akr1b7 Cre transgenic mice, resulting thereby in deletion of MyD88, which was adrenocortical-specific. Although reduced adrenal inflammation and HPA-axis activation mediated by LPS were found in Mx1(Cre+)-MyD88(fl/fl) mice, adrenocortical-specific MyD88 deletion did not alter the adrenal inflammation or HPA-axis activity under systemic inflammatory response syndrome conditions. Thus, our data suggest an important role of immune cell rather than adrenocortical MyD88 for adrenal inflammation and HPA-axis activation mediated by LPS.
炎症相关的下丘脑-垂体-肾上腺 (HPA) 轴失调是全身炎症反应综合征或败血症的核心。然而,其潜在机制尚不清楚。早期败血症中肾上腺皮质激素产生的初始激活依赖于细胞因子介导的下丘脑和垂体的刺激;在晚期败血症中,存在从神经内分泌到糖皮质激素产生的局部免疫-肾上腺调节的转变。因此,调节局部免疫-肾上腺的相互作用,而不是涉及促肾上腺皮质激素产生的神经内分泌回路,可能更有希望预防与长期败血症相关的肾上腺功能不全。在本工作中,我们研究了关键 Toll 样受体 (TLR) 衔接蛋白髓样分化因子 88 (MyD88) 在脂多糖 (LPS) 介导的全身和局部激活肾上腺炎症和糖皮质激素产生中的功能。为此,我们使用了具有条件性 MyD88 等位基因的小鼠。这些小鼠要么与 Mx1 Cre 小鼠杂交,导致全身 MyD88 缺失,主要在肝脏和造血系统中,要么与 Akr1b7 Cre 转基因小鼠杂交,导致 MyD88 缺失,这是肾上腺特异性的。尽管在 Mx1(Cre+)-MyD88(fl/fl) 小鼠中发现 LPS 介导的肾上腺炎症和 HPA 轴激活减少,但肾上腺特异性 MyD88 缺失并没有改变全身炎症反应综合征条件下的肾上腺炎症或 HPA 轴活性。因此,我们的数据表明,免疫细胞而不是肾上腺皮质的 MyD88 在 LPS 介导的肾上腺炎症和 HPA 轴激活中起重要作用。